Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide
about
Acute promyelocytic leukemia: where did we start, where are we now, and the futureRetinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.Second primary malignancy in acute promyelocytic leukemia: a Surveillance, Epidemiology and End Results database study.Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.
P2860
Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@ast
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@en
type
label
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@ast
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@en
prefLabel
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@ast
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@en
P2093
P2860
P50
P1433
P1476
Incidence of secondary neoplas ...... oic acid plus arsenic trioxide
@en
P2093
Alireza Eghtedar
Ildefonso Rodriguez
Naval Daver
P2860
P304
P356
10.3109/10428194.2014.953143
P50
P577
2014-11-03T00:00:00Z